Bausch + Lomb Corporation (NYSE:BLCO) Stock Has Consensus Target Price of $19.15

Posted by Brenda Bartman on Sep 27th, 2026

Shares of Bausch + Lomb Corporation (NYSE:BLCO – Get Free Report) have been assigned an average recommendation of “Hold” from the fifteen ratings firms that are presently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, eight have assigned a hold recommendation and six have given a buy recommendation to the company. The average twelve-month target price among brokers that have issued a report on the stock in the last year is $19.15.

A number of equities research analysts recently weighed in on BLCO shares. Leerink Partners assumed coverage on Bausch + Lomb in a research report on Wednesday, September 9th. They set an “outperform” rating and a $24.00 target price on the stock. Citigroup raised their price objective on Bausch + Lomb from $19.00 to $21.00 and gave the stock a “buy” rating in a research report on Wednesday, July 8th. Weiss Ratings raised Bausch + Lomb from a “sell (e+)” rating to a “sell (d-)” rating in a report on Friday, August 21st. Needham & Company LLC restated a “hold” rating on shares of Bausch + Lomb in a research report on Tuesday, September 15th. Finally, HC Wainwright restated a “buy” rating and issued a $21.00 target price on shares of Bausch + Lomb in a research note on Friday, August 28th.

Get Our Latest Research Report on Bausch + Lomb

Insiders Place Their Bets

In other news, Director Eschenbach Andrew C. Von sold 6,059 shares of the stock in a transaction on Friday, August 7th. The shares were sold at an average price of $16.58, for a total value of $100,458.22. Following the completion of the transaction, the director owned 63,733 shares in the company, valued at approximately $1,056,693.14. This represents a 8.68% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CAO Frederick Munsch sold 52,900 shares of the firm’s stock in a transaction dated Monday, August 10th. The stock was sold at an average price of $16.78, for a total transaction of $887,662.00. Following the transaction, the chief accounting officer directly owned 45,831 shares of the company’s stock, valued at $769,044.18. The trade was a 53.58% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 71,459 shares of company stock worth $1,194,370 in the last quarter. Corporate insiders own 1.45% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the business. Engineers Gate Manager LP acquired a new stake in Bausch + Lomb during the second quarter valued at approximately $1,479,000. Whitebox Advisors LLC raised its holdings in shares of Bausch + Lomb by 15.8% in the 1st quarter. Whitebox Advisors LLC now owns 1,101,854 shares of the company’s stock worth $17,519,000 after buying an additional 150,641 shares in the last quarter. Sei Investments Co. lifted its position in shares of Bausch + Lomb by 100.0% during the 1st quarter. Sei Investments Co. now owns 139,266 shares of the company’s stock worth $2,214,000 after buying an additional 69,633 shares during the period. Knights of Columbus Asset Advisors LLC bought a new position in shares of Bausch + Lomb during the 4th quarter worth approximately $605,000. Finally, Fox Run Management L.L.C. acquired a new stake in Bausch + Lomb in the 4th quarter valued at $787,000. Institutional investors and hedge funds own 11.07% of the company’s stock.

Bausch + Lomb Price Performance

Shares of Bausch + Lomb stock opened at $16.90 on Tuesday. The company has a debt-to-equity ratio of 0.79, a current ratio of 1.55 and a quick ratio of 1.02. Bausch + Lomb has a fifty-two week low of $13.77 and a fifty-two week high of $18.92. The firm has a fifty day moving average price of $17.03 and a two-hundred day moving average price of $16.39. The company has a market cap of $6.04 billion, a PE ratio of -35.21, a price-to-earnings-growth ratio of 0.53 and a beta of 0.56.

Bausch + Lomb (NYSE:BLCO – Get Free Report) last posted its quarterly earnings results on Wednesday, July 29th. The company reported $0.15 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.16 by ($0.01). The company had revenue of $1.39 billion during the quarter, compared to analyst estimates of $1.37 billion. Bausch + Lomb had a positive return on equity of 4.14% and a negative net margin of 3.21%.The business’s revenue for the quarter was up 9.1% on a year-over-year basis. During the same quarter in the prior year, the business earned ($0.18) earnings per share. Analysts expect that Bausch + Lomb will post 0.81 EPS for the current year.

About Bausch + Lomb

(Get Free Report)

Bausch + Lomb Corporation (NYSE: BLCO) is a global eye-health company that develops, manufactures and markets products for vision care, pharmaceuticals and surgical use. Its portfolio serves consumers, eye-care professionals and patients with a range of products designed to support eye health and improve vision.

The company’s vision-care business includes contact lenses and lens-care products, while its pharmaceutical portfolio includes prescription and over-the-counter treatments for conditions affecting the eyes.